-
Public consultation on the guidelines on the advertising of medicinal products
The Danish Medicines Agency has sent two new draft guidelines on the advertising of medicinal products for respectively humans and animals out for consultation with a deadline of 1 March 2022. The drafts contain specifications within several areas, including in relation to the use of SoMe and vaccination campaigns.
Article - 16.02.2022
-
Medical device news
The European Commission’s extended transition period regarding in vitro diagnostic medical devices has come into force, and new guidelines have been issued regarding clinical evidence for in vitro diagnostic medical devices and regarding electronic instructions for use.
Article - 14.02.2022
-
News regarding the Danish Medicines Council - conditional recommendations to be used as of 2022
The board of the Danish Regions has decided that as of 1 January 2022, and for a limited period, the Danish Medicines Council can issue conditional recommendations regarding medicinal products.
Article - 03.11.2021
-
Medical device news
The European Commission launches modules 2 and 3 of EUDAMED, and the Medical Device Coordination Group has published two new guidance documents.
Article - 12.10.2021
-
News from the Danish Medicines Council - reassessments must be made according to the QALY measure as of 1 June 2022
The Danish Medicines Council has just announced that come 1 June 2022, the Council will make reassessments according to the new assessment methods comprising the QALY measure. This will apply for all recommendations - regardless of when they were made.
Article - 13.09.2021
-
New executive orders and guidelines on medical devices
On 26 May 2021, Regulation (EU) 2017/745 on medical devices entered into force. Consequently, the authorities have updated a number of Danish executive orders and guidelines and have also issued several new sets of rules in this field.
Article - 08.06.2021
-
The new regulation on medical devices has now entered into force - what does that entail?
The new regulation (EU) 2017/745 on medical devices came into force on 26 May 2021 repealing the former directives in the field. With the new regulation, operators within the medical devices industry face more stringent obligations. In the following, we describe what these operators will have to pay attention to.
Article - 25.05.2021
-
New rules on HCP relationships and economic support to HCPs come into force on 26 May 2021
The amendments to the rules on HCP relationships with companies and economic support to HCPs come into force on 26 May 2021. Among other things, the amended rules concern the group of comprised companies, the obligation to report economic support, and the obligation to make notifications or seek permission regarding HCP relationships.
Article - 25.05.2021